.avif)
Global Blood Therapeutics Email Format
Pharmaceutical Manufacturing
・
10,001+ employees
・
New York, NY, USA
Global Blood Therapeutics is a biopharmaceutical company focused on discovering, developing, and delivering innovative treatments for patients with sickle cell disease and other blood disorders.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@gbt.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
2011
Headquarters
New York, NY, USA
Revenue
$50B-$100B
FUNDING Stage
Acquired
Website
Key Executives
Albert Bourla (Chairman and Chief Executive Officer), Nazila Habibizad (Executive Vice President, Operations), Susan Rienow (Global Chief Marketing Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Global Blood Therapeutics?
Global Blood Therapeutics uses the firstinitiallast format on gbt.com, so Jane Smith would be jsmith@gbt.com.
What is Global Blood Therapeutics' lead approved therapy for sickle cell disease?
Global Blood Therapeutics developed Oxbryta (voxelotor), the first FDA-approved oral medicine to directly inhibit sickle hemoglobin polymerization. It received FDA accelerated approval in November 2019 for patients 12 and older, with a later expansion to children as young as 4.
Which countries outside the US did Global Blood Therapeutics secure regulatory approval for Oxbryta in?
Global Blood Therapeutics obtained marketing authorization for Oxbryta in the European Union, Great Britain, and across the six Gulf Cooperation Council countries, including Saudi Arabia, the United Arab Emirates, Kuwait, Oman, Qatar, and Bahrain.
How was Global Blood Therapeutics founded and what was its original focus?
Global Blood Therapeutics was founded in 2011 in South San Francisco with a singular focus on developing treatments for sickle cell disease, a historically underserved rare blood disorder. Ted Love became its president and CEO in 2014 and led the company through the Oxbryta approval.
How can I find the right Global Blood Therapeutics contact for outreach or prospecting?
Since Global Blood Therapeutics uses the firstinitiallast@gbt.com format, you can combine a contact's first initial and last name to build their address. Tools like Clay can help you verify those addresses and enrich your prospect list with current role and contact details.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating